ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MDCN Medican Enterprises Inc (CE)

0.000001
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Medican Enterprises Inc (CE) USOTC:MDCN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.000001 0.000001 0.000001 1,650,000 01:00:00

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

27/01/2017 4:03pm

Edgar (US Regulatory)




 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
  OMB APPROVAL
OMB Number:
3235-0167
Expires:
March 31, 2018
  Estimated average burden hours
  per response . . . . . 1.50
 
FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number
000-53408
 
  Medican Enterprises, Inc.  
(Exact name of registrant as specified in its charter)
 
   
245 E Liberty Street, STE 200, Reno, Nevada, 89501    (734)883-0539
 
 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)  
   
 Common Stock, $0.001 par value  
(Title of each class of securities covered by this Form)   
   
None   
 (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)  

        Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
   ☐
Rule 12h-3(b)(1)(ii)
   ☐
Rule 15d-6
   ☐
Rule 15d-22(b)
   ☐
 
        Approximate number of holders of record as of the certification or notice date:     209             
 
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:  January 23rd, 2017     By:     Ken Williams, CEO, Sole Director and Majority Shareholder         With Voting Control
 
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.


 
SEC 2069 (08-11) Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
 
 

 

1 Year Medican Enterprises (CE) Chart

1 Year Medican Enterprises (CE) Chart

1 Month Medican Enterprises (CE) Chart

1 Month Medican Enterprises (CE) Chart

Your Recent History